10x Genomics Quarterly Balance Sheet
NASDAQ: TXGIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
10x Genomics financial position
As of Jun 30, 2026, 10x Genomics reported total assets of $1.03 billion, up 5.1% from a year earlier against total liabilities of $204.5 million. Shareholders' equity stood at $825.5 million, or 80.1% of assets. The company held $502.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.69, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
10x Genomics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 502.51M | 490.29M | 473.97M | 432.71M | 397.71M | 377.06M | 344.07M | 398.16M | 379.82M | 355.78M | 359.28M | 314.74M |
| Short-Term Investments | 49.52M | 49.56M | 49.44M | 49.58M | 49.55M | 49.84M | 49.34M | 0 | 269.00K | 16.03M | 29.41M | 45.64M |
| Receivables | 47.55M | 39.03M | 47.01M | 43.78M | 49.98M | 52.55M | 87.86M | 83.53M | 91.18M | 91.31M | 114.83M | 103.85M |
| Inventory | 52.62M | 53.49M | 56.34M | 61.96M | 68.97M | 74.71M | 83.11M | 94.05M | 88.27M | 83.19M | 73.71M | 80.92M |
| Total Current Assets | 674.67M | 669.73M | 684.45M | 659.83M | 655.66M | 579.73M | 584.39M | 593.89M | 579.15M | 567.09M | 596.02M | 562.35M |
| Property, Plant & Equipment | 215.32M | 220.59M | 226.71M | 232.53M | 239.71M | 246.09M | 252.65M | 258.76M | 263.29M | 269.49M | 279.57M | 285.01M |
| Goodwill | 6.92M | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M |
| Intangible Assets | 61.16M | 59.91M | 62.33M | 64.76M | 14.71M | 15.19M | 15.67M | 16.15M | 16.66M | 16.13M | 16.62M | 21.83M |
| Total Assets | 1.03B | 1.02B | 1.04B | 1.03B | 979.97M | 903.39M | 918.64M | 937.79M | 929.67M | 922.91M | 965.14M | 948.54M |
| Accounts Payable | 20.69M | 17.43M | 12.73M | 18.07M | 15.94M | 10.07M | 12.91M | 26.21M | 21.25M | 20.22M | 15.74M | 18.84M |
| Total Current Liabilities | 118.51M | 113.60M | 153.45M | 147.32M | 112.22M | 107.90M | 117.63M | 121.23M | 111.02M | 108.73M | 127.16M | 104.72M |
| Total Liabilities | 204.52M | 201.44M | 245.04M | 242.24M | 206.69M | 196.50M | 208.50M | 214.99M | 205.61M | 204.08M | 224.10M | 203.32M |
| Shareholders' Equity | 825.55M | 814.32M | 796.33M | 785.12M | 773.28M | 706.89M | 710.13M | 722.80M | 724.06M | 718.83M | 741.04M | 745.22M |
| Retained Earnings | -1.54B | -1.52B | -1.51B | -1.49B | -1.47B | -1.50B | -1.47B | -1.42B | -1.38B | -1.34B | -1.28B | -1.24B |
| Net Cash (Debt) | 552.03M | 539.85M | 523.41M | 482.29M | 447.26M | 426.90M | 393.40M | 398.16M | 380.09M | 371.81M | 388.69M | 360.38M |
| Shares Outstanding | — | — | 127.69M | — | — | — | 122.29M | — | — | — | 119.10M | — |
This table shows 12 quarterly periods of 10x Genomics's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TXG's reporting calendar. What is a balance sheet?